✦ LIBER ✦

Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience

✍ Scribed by D. A. PEURA; D. C. METZ; A. H. DABHOLKAR; M. M. PARIS; P. YU; S. N. ATKINSON

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials: healing of erosive oeso

✍ P. SHARMA; N. J. SHAHEEN; M. C. PEREZ; B. L. PILMER; M. LEE; S. N. ATKINSON; D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

The 12-month safety profile of dexlansop

✍ A. H. Dabholkar; C. Han; M. M. Paris; M. C. Perez; S. N. Atkinson; D. A. Peura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Review article: dual delayed release for

✍ D. C. METZ; M. VAKILY; T. DIXIT; D. MULFORD 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

Clinical trial: dexlansoprazole MR, a pr

✍ D. C. METZ; C. W. HOWDEN; M. C. PEREZ; L. LARSEN; J. O’NEIL; S. N. ATKINSON 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Clinical trial: the effect and timing of

✍ R. D. LEE; M. VAKILY; D. MULFORD; J. WU; S. N. ATKINSON 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

The effect of time-of-day dosing on the

✍ R. D. LEE; D. MULFORD; J. WU; S. N. ATKINSON 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB